Malhi, Gin S. http://orcid.org/0000-0002-4524-9091
Das, Pritha
Bell, Erica http://orcid.org/0000-0002-8483-8497
Mattingly, Greg http://orcid.org/0000-0002-0234-6860
Mannie, Zola
Article History
Received: 1 May 2019
Revised: 24 October 2019
Accepted: 6 November 2019
First Online: 26 November 2019
Conflict of interest
: G.S.M. has received grant or research support from Australian Rotary Health, the NHMRC, NSW Health, Ramsay Health, The University of Sydney, American Foundation for Suicide Prevention, AstraZeneca, Eli Lilly & Co., Organon, Pfizer, Servier and Wyeth; has been a speaker for AstraZeneca, Otsuka, Janssen Cilag, Lundbeck, Pfizer, Servie and Wyeth; and has been a consultant for AstraZeneca, Eli Lilly & Co., Janssen Cilag, Lundbeck and Servier. G.M. serves as a Speaker for Alkermes, Allergan, Janssen, Lundbeck, Otsuka, Sunovion and Takeda. He also serves as a Consultant for Akili, Alkermes, Allergan, Axsome, Ironshore, Intracellular, Janssen, Lundbeck, Otsuka, Neos, Purdue, Rhodes, Sage, Shire, Sunovion, Takeda and Teva. Additionally, he serves as a Researcher for Akili, Alkermes, Allergan, Boehringer, Janssen, Medgenics, NLS-1 Pharma AG, Otsuka, Reckitt Benckiser, Roche, Sage, Sunovion, Supernus and Takeda. P.D., E.B. and Z.M. have no conflicts of interest to report.